vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $50.3M, roughly 1.2× READING INTERNATIONAL INC). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -70.9%, a 65.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 5.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
CTKB vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $50.3M |
| Net Profit | $-44.1M | $-2.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -1.9% |
| Net Margin | -70.9% | -5.1% |
| Revenue YoY | 8.1% | -14.2% |
| Net Profit YoY | -557.1% | -14.5% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $50.3M | ||
| Q3 25 | $52.3M | $52.2M | ||
| Q2 25 | $45.6M | $60.4M | ||
| Q1 25 | $41.5M | $40.2M | ||
| Q4 24 | $57.5M | $58.6M | ||
| Q3 24 | $51.5M | $60.1M | ||
| Q2 24 | $46.6M | $46.8M | ||
| Q1 24 | $44.9M | $45.1M |
| Q4 25 | $-44.1M | $-2.6M | ||
| Q3 25 | $-5.5M | $-4.2M | ||
| Q2 25 | $-5.6M | $-2.7M | ||
| Q1 25 | $-11.4M | $-4.8M | ||
| Q4 24 | $9.6M | $-2.2M | ||
| Q3 24 | $941.0K | $-7.0M | ||
| Q2 24 | $-10.4M | $-12.8M | ||
| Q1 24 | $-6.2M | $-13.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -1.9% | ||
| Q3 25 | -17.6% | -0.6% | ||
| Q2 25 | -23.3% | 4.8% | ||
| Q1 25 | -36.1% | -17.2% | ||
| Q4 24 | 5.2% | 2.6% | ||
| Q3 24 | -8.2% | -0.6% | ||
| Q2 24 | -18.3% | -16.4% | ||
| Q1 24 | -23.9% | -16.7% |
| Q4 25 | -70.9% | -5.1% | ||
| Q3 25 | -10.5% | -8.0% | ||
| Q2 25 | -12.2% | -4.4% | ||
| Q1 25 | -27.5% | -11.8% | ||
| Q4 24 | 16.8% | -3.8% | ||
| Q3 24 | 1.8% | -11.7% | ||
| Q2 24 | -22.4% | -27.4% | ||
| Q1 24 | -13.8% | -29.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $341.7M | $-18.2M |
| Total Assets | $461.5M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $10.5M | ||
| Q3 25 | $93.3M | $8.1M | ||
| Q2 25 | $75.5M | $9.1M | ||
| Q1 25 | $95.3M | $5.9M | ||
| Q4 24 | $98.7M | $12.4M | ||
| Q3 24 | $162.3M | $10.1M | ||
| Q2 24 | $177.9M | $9.3M | ||
| Q1 24 | $168.8M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $-18.2M | ||
| Q3 25 | $378.6M | $-12.1M | ||
| Q2 25 | $377.6M | $-7.7M | ||
| Q1 25 | $379.6M | $-8.1M | ||
| Q4 24 | $395.7M | $-4.4M | ||
| Q3 24 | $385.5M | $1.6M | ||
| Q2 24 | $389.1M | $6.5M | ||
| Q1 24 | $392.6M | $18.0M |
| Q4 25 | $461.5M | $434.9M | ||
| Q3 25 | $494.9M | $435.2M | ||
| Q2 25 | $493.3M | $438.1M | ||
| Q1 25 | $482.6M | $441.0M | ||
| Q4 24 | $499.5M | $471.0M | ||
| Q3 24 | $491.2M | $495.7M | ||
| Q2 24 | $483.7M | $494.9M | ||
| Q1 24 | $492.1M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $4.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $4.1M |
| FCF MarginFCF / Revenue | -2.9% | 8.2% |
| Capex IntensityCapex / Revenue | 1.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $4.3M | ||
| Q3 25 | $-3.9M | $295.0K | ||
| Q2 25 | $108.0K | $1.6M | ||
| Q1 25 | $-125.0K | $-7.7M | ||
| Q4 24 | $2.0M | $8.0M | ||
| Q3 24 | $13.2M | $1.3M | ||
| Q2 24 | $6.2M | $-10.4M | ||
| Q1 24 | $4.0M | $-2.8M |
| Q4 25 | $-1.8M | $4.1M | ||
| Q3 25 | $-4.6M | $-246.0K | ||
| Q2 25 | $-1.5M | $1.2M | ||
| Q1 25 | $-974.0K | $-8.0M | ||
| Q4 24 | $1.1M | $7.0M | ||
| Q3 24 | $12.2M | $-1.1M | ||
| Q2 24 | $5.2M | $-10.6M | ||
| Q1 24 | $3.4M | $-4.7M |
| Q4 25 | -2.9% | 8.2% | ||
| Q3 25 | -8.7% | -0.5% | ||
| Q2 25 | -3.2% | 1.9% | ||
| Q1 25 | -2.3% | -19.8% | ||
| Q4 24 | 1.9% | 12.0% | ||
| Q3 24 | 23.7% | -1.8% | ||
| Q2 24 | 11.0% | -22.7% | ||
| Q1 24 | 7.6% | -10.4% |
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 1.3% | 1.0% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 1.7% | ||
| Q3 24 | 2.0% | 4.0% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
